scorecardresearch
Add as a preferred source on Google
Friday, April 10, 2026
TopicCureVac

Topic: CureVac

GlaxoSmithKline, CureVac team up to develop vaccines to tackle Covid variants

Suzi Ring -
The immunisations may be used to protect people who haven’t been inoculated or as booster shots if immunity from other vaccines wanes.

Covid vaccine contender CureVac BV shares soar 249% in US trading debut

Crystal Tse -
CureVac, based in Tubingen, Germany, said in June that it received regulatory approval to begin Phase 1 trials of its vaccine candidate. It said it expects the results in the fourth quarter.

On Camera

YourTurn

Opinion

What can be expected from the ongoing talks in Islamabad? Odds of resolution remain slim

Swasti Rao -
The initial ceasefire functioned less as a resolution and more as a pause—an opportunity for both sides to recalibrate, while claiming victory.

Pig politicisation isn’t unique to Delhi’s Tri Nagar. It’s a worldwide anti-Muslim strategy

Tamil Nadu’s elections are fought on delivery—ideology appears only when needed

Economy

India bond yields rise as RBI moves to drain liquidity, lift overnight rates

Bloomberg News -
New Delhi: India’s sovereign bond yields rose after the central bank announced its first step this year to drain cash from the banking system,...

Defence

Army promotes Col Purohit, acquitted in 2008 Malegaon blast case, to Brigadier; to not retire yet

Snehesh Alex Philip -
This means he will serve Indian Army for a minimum of another 2 years as Brigadier, unless he picks up the next rank of Major General.

National Interest

China insulated itself against energy shocks. India is ‘all talk, no walk’

Shekhar Gupta -
China patiently invested capital, skill and technology in coal gasification. Unlike it, we won’t move from words to action. As crude prices decline, we lose interest.

Follow us

Copyright © 2025 Printline Media Pvt. Ltd. All rights reserved.